AI brief of an SEC Form 8-K · Inogen Inc (INGN)

Inogen posts wider Q3 loss of $14.8 million as revenue falls 2.4% to $77.2 million

Negative Impact 4 of 5 earnings Written later

Inogen reported third-quarter 2026 results with revenue down 2.4% and a larger GAAP loss from continuing operations than a year earlier, including a $10.6 million impairment charge. The company also completed the sale of its U.S. oxygen rental business and named Andy Reding as President and CEO, replacing Kevin Smith.

Key points

  • Q3 2026 revenue was $77.2 million, down from $79.1 million; U.S. sales rose 3.8% while international sales fell 9.0%.
  • GAAP loss from continuing operations was $14.8 million ($0.56 per diluted share) versus $3.6 million ($0.13) a year earlier.
  • Fourth-quarter 2026 revenue from continuing operations is expected at $65 million to $68 million; full-year revenue at $298 million to $301 million, with an adjusted loss of $7 million to $8 million.
  • Andy Reding became President and CEO effective October 30, 2026; the company also plans a $20 million annualized cost reduction program starting in Q4 2026.

The filing

CompanyInogen Inc (INGN)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:08 PM ET
Accession number0001294133-26-000040

Items reported: 2.01 Acquisition or Disposition Completed2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.